MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
4.66 M |
Market Cap[1] |
$ 1.54 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.32 |
EPS (LTM) |
1.68 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.92 | 0.56 % | $ 594 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 13.76 | 0.81 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Castle Biosciences
CSTL
|
$ 26.01 | 0.68 % | $ 722 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DexCom
DXCM
|
$ 68.2 | 2.8 % | $ 26.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 154.35 | 1.57 % | $ 7.65 B | NYSE,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.52 | 1.18 % | $ 934 M | Nasdaq Global Market,SPB | USA |
 |
Guardant Health
GH
|
$ 87.53 | 0.4 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.87 | 0.01 % | $ 19.6 B | Nasdaq Capital Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Fulgent Genetics
FLGT
|
$ 15.53 | 3.88 % | $ 470 M | Nasdaq Global Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 17.01 | -1.62 % | $ 2.21 B | Nasdaq Global Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 99.43 | 1.86 % | $ 8.2 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Anixa Biosciences
ANIX
|
$ 2.9 | 2.11 % | $ 94.1 K | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 168.32 | 2.14 % | $ 28.9 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 194.97 | 1.87 % | $ 139 B | NYSE,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 121.42 | 1.79 % | $ 19.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 199.2 | 0.13 % | $ 22.1 B | NYSE,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Agilent Technologies
A
|
$ 113.43 | 1.43 % | $ 34.5 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.12 | 0.66 % | $ 1.42 M | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 9.28 | 10.24 % | $ 263 M | Nasdaq Capital Market | Israel |
 |
NeoGenomics
NEO
|
$ 8.36 | 1.46 % | $ 1.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.24 | 1.43 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 78.46 | -0.05 % | $ 5.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.41 | 3.31 % | $ 423 M | Nasdaq Global Select Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 452.71 | -0.21 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Mettler-Toledo International
MTD
|
$ 1 215.3 | 1.35 % | $ 25 B | NYSE,SPB |  Schweiz |
 |
Celcuity
CELC
|
$ 114.14 | -0.66 % | $ 4.5 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.95 | 3.16 % | $ 402 M | Nasdaq Global Select Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Natera
NTRA
|
$ 199.43 | 0.89 % | $ 19.6 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.2 | 0.42 % | $ 833 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.